Novavax says COVID vaccine for U.S. to be manufactured by India's Serum
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall St set to fall at open as yields and oil rebound; Fed minutes in focus
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
- HubSpot to cut 7% of workforce in restructuring plan
- Caribou Biosciences to halt CAR-T programs, explore sale
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Stryker names Spencer Stiles as CEO, Lobo moves to chair
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
Novavax's (NVAX) Covid-19 Vaccine Approval in the U.S. Could Be Delayed - CNBC
June 9, 2022 10:16 AM EDTThe U.S. Food and Drug Administration's (FDA) decision on Novavax's (NASDAQ: NVAX) Covid-19 vaccine could be delayed, according to a report by CNBC.
An FDA spokesperson told CNBC that the regulatory body will have to review modifications to the drugmakers... More
Novavax (NVAX) Covid Vaccine Wins Backing of FDA Panel in Vote of 20 to 0 with 1 Abstain
June 7, 2022 3:30 PM EDTNovavax (NASDAQ: NVAX) Covid Vaccine Wins Backing of FDA Panel in Vote of 20 to 0 with 1 Abstain
... More


